OLGU SUNUMLARI
COVID-19 İlişkili Hemorajik İnmeli Hastada Antikoagülan Tedaviye Rağmen Derin Ven Trombozu
Deep Vein Thrombosis Despite Anticoagulant Therapy in a Patient with COVID-19 Related Hemorrhagic Stroke
Received Date : 01 Aug 2022
Accepted Date : 14 May 2023
Available Online : 22 May 2023
Cemile Sevgi POLATa, Güldal Funda NAKİPOĞLU YÜZERa, Kerim DEMİRSÖZa
aClinic of Bilkent Physical Medicine and Rehabilitation, Ankara City Hospital, Ankara, Türkiye
Doi: 10.31609/jpmrs.2022-92704 - Makale Dili: EN
J PMR Sci. 2023;26(3):368-71
ÖZET
Koronavirüs hastalığı-2019 [coronavirus disease-2019 (COVID-
19)], şiddetli akut solunum sendromu-koronavirüs-2’nin neden olduğu viral
bir enfeksiyondur ve Dünya Sağlık Örgütü tarafından Mart 2020’de pandemi
olarak ilan edilmiştir. COVID-19 esas olarak solunum sistemini etkilemekle
birlikte multisistem bir hastalıktır ve nörolojik tutulum da
görülebilir. Bu olgu sunumunda, COVID-19 ilişkili hemorajik inme hastasında
rehabilitasyon sürecinde antikoagülan tedavi kullanımı ve ambulasyona
rağmen derin ven trombozu gelişimini sunduk. COVID-19 un
trombojenik etkisinden dolayı COVID-19 ilişkili inmede venöz tromboz
riski yüksek olabilir.
Anahtar Kelimeler: COVID-19; hemorajik inme; antikoagülan tedavi; derin ven trombozu
ABSTRACT
Coronavirus disease-2019 (COVID-19) is a viral infection
caused by the severe acute respiratory syndrome-coronavirus-2 and was declared
a global pandemic by the World Health Organization on March 2020.
Although COVID-19 mainly effects the respiratory system, it is a multisystem
disease and neurological involvement may also occur. In this case, we
reported a patient with COVID-19 related hemorrhagic stroke and indicated
the development of deep vein thrombosis despite anticoagulant therapy and
ambulation of the patient in the stroke rehabilitation process. The risk of venous
thrombosis may be high in COVID-19-related stroke due to the thrombogenic
effect of COVID-19.
Keywords: COVID-19; hemorrhagic stroke; anticoagulant therapy; deep vein thrombosis
REFERENCES
- Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683-90. [Crossref] [PubMed] [PMC]
- Yaghi S, Ishida K, Torres J, et al. SARS-CoV-2 and stroke in a New York healthcare system. Stroke. 2020;51:2002-11. Erratum in: Stroke. 2020;51:e179. [Crossref] [PubMed] [PMC]
- Sharifi-Razavi A, Karimi N, Rouhani N. COVID-19 and intracerebral haemorrhage: causative or coincidental? New Microbes New Infect. 2020;35:100669. [Crossref] [PubMed] [PMC]
- Li Y, Li M, Wang M, et al. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol. 2020;3:279-84. [Crossref] [PubMed] [PMC]
- Beyrouti R, Adams ME, Benjamin L, et al. Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry. 2020;91:889-91. [Crossref] [PubMed] [PMC]
- Wu Y, Xu X, Chen Z, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020;87:18-22. [Crossref] [PubMed] [PMC]
- Md Noh MSF. COVID-19 and cerebral hemorrhage: proposed mechanisms. J Neuroradiol. 2021;48:125-6. [Crossref] [PubMed] [PMC]
- Paciaroni M, Agnelli G, Alberti A, et al. PREvention of VENous thromboembolism in hemorrhagic stroke patients - PREVENTIHS study: a randomized controlled trial and a systematic review and meta-analysis. Eur Neurol. 2020;83:566-75. [Crossref] [PubMed]
- Qian C, Huhtakangas J, Juvela S, et al. Early vs. late enoxaparin for the prevention of venous thromboembolism in patients with ICH: A double blind placebo controlled multicenter study. Clin Neurol Neurosurg. 2021;202:106534. [Crossref] [PubMed]
- Cai Q, Zhang X, Chen H. Patients with venous thromboembolism after spontaneous intracerebral hemorrhage: a review. Thromb J. 2021;19:93. [Crossref] [PubMed] [PMC]
- Dogra S, Jain R, Cao M, et al. Hemorrhagic stroke and anticoagulation in COVID-19. J Stroke Cerebrovasc Dis. 2020;29:104984. [Crossref] [PubMed] [PMC]
- Middeldorp S, Coppens M, van Haaps TF, et al. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020;18:1995-2002. [PubMed] [PMC]
- Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145-7. [Crossref]
- Llitjos JF, Leclerc M, Chochois C, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. 2020;18:1743-6. [Crossref] [PubMed] [PMC]
- Levi M, Thachil J, Iba T, et al. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7:e438-e40. [Crossref] [PubMed] [PMC]
- Mahboob S, Boppana SH, Rose NB, et al. Large vessel stroke and COVID-19: Case report and literature review. eNeurologicalSci. 2020;20:100250. [Crossref] [PubMed] [PMC]
- Wang T, Chen R, Liu C, et al. Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19. Lancet Haematol. 2020;7:e362-e3. [Crossref] [PubMed] [PMC]
